coccidioidomycosis
Information
- Disease name
- coccidioidomycosis
- Disease ID
- DOID:13450
- Description
- "A primary systemic mycosis that results_in systemic fungal infection, has_material_basis_in Coccidioides immitis, transmitted_by airborne spores and has_symptom conjunctivitis, has_symptom arthritis, has_symptom chest pain and results_in_formation_of skin nodules." [url:http\://www.merck.com/mmhe/sec17/ch197/ch197e.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04208321 | Completed | Phase 1 | Safety and Pharmacokinetics of VT-1598 | September 29, 2020 | December 27, 2021 |
| NCT00423267 | Completed | Phase 3 | POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED) | May 2007 | May 2009 |
| NCT03908632 | Completed | An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC) | February 14, 2019 | December 5, 2023 | |
| NCT00690092 | Completed | Phase 3 | A Multi-center Study of Spherule-Derived Coccidioidin | May 2005 | September 2007 |
| NCT00796809 | Completed | Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis | October 2007 | October 2008 | |
| NCT03059992 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment | April 1, 2017 | August 17, 2023 |
| NCT00002325 | Completed | N/A | A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common | ||
| NCT02190266 | Recruiting | Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis | September 2, 2014 | July 31, 2029 | |
| NCT02663674 | Terminated | Phase 4 | Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever) | December 29, 2015 | July 31, 2018 |
| NCT00614666 | Terminated | Phase 1/Phase 2 | Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment | September 2007 | September 2009 |
| NCT03618992 | Terminated | N/A | Improving the Appearance of Skin and Hair in Patients Undergoing Valley Fever Treatment | August 1, 2018 | May 31, 2020 |
| NCT02908334 | Withdrawn | Phase 2 | Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis | November 2016 | January 22, 2019 |
| NCT04809649 | Withdrawn | Phase 2 | SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole | May 15, 2021 | September 2022 |
- Disase is a (Disease Ontology)
- DOID:0050292
- Cross Reference ID (Disease Ontology)
- GARD:9525
- Cross Reference ID (Disease Ontology)
- ICD10CM:B38
- Cross Reference ID (Disease Ontology)
- ICD9CM:114
- Cross Reference ID (Disease Ontology)
- MESH:D003047
- Cross Reference ID (Disease Ontology)
- NCI:C84642
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:266218008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0009186
- Exact Synonym (Disease Ontology)
- primary extrapulmonary coccidioidomycosis
- OrphaNumber from OrphaNet (Orphanet)
- 228123
- MedGen concept unique identifier (MedGen Concept name)
- CN201384
- MedGen unique identifier (MedGen Concept name)
- 1435302
- ICD10 preferred id (Insert disease from ICD10)
- D0000644
- ICD10 class code (Insert disease from ICD10)
- B38
- MeSH unique ID (MeSH (Medical Subject Headings))
- D003047